These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 6502916)
41. Central GABA-ergic stimulation attenuates hypertension and hypothalamic hyperactivity in spontaneously hypertensive rats. Sasaki S; Lee LC; Iyota I; Kambara S; Okajima H; Inoue A; Takahashi H; Takeda K; Yoshimura M; Nakagawa M J Hypertens Suppl; 1986 Oct; 4(3):S171-4. PubMed ID: 3465896 [TBL] [Abstract][Full Text] [Related]
42. Natriuretic and antihypertensive effects of potassium in DOCA-salt hypertensive rats. Fujita T; Sato Y Kidney Int; 1983 Dec; 24(6):731-9. PubMed ID: 6325798 [TBL] [Abstract][Full Text] [Related]
43. Role of the renal nerves in the maintenance of DOCA-salt hypertension in the rat. Influence on the renal vasculature and sodium excretion. Katholi RE; Naftilan AJ; Bishop SP; Oparil S Hypertension; 1983; 5(4):427-35. PubMed ID: 6345357 [TBL] [Abstract][Full Text] [Related]
44. Central action of sodium chloride on whole body pressor responsiveness in the DOCA-treated rat. Soltis EE; Bohr DF J Hypertens; 1989 May; 7(5):383-6. PubMed ID: 2768824 [TBL] [Abstract][Full Text] [Related]
45. Role of hypothalamic-renal noradrenergic systems in hypotensive action of potassium. Fujita T; Sato Y Hypertension; 1992 Oct; 20(4):466-72. PubMed ID: 1356921 [TBL] [Abstract][Full Text] [Related]
46. Time course alterations in vascular adrenergic responsiveness in the DOCA/NaCl-treated rat. Katovich MJ; Soltis EE; Iloeje E; Field FP Pharmacology; 1984; 29(3):173-80. PubMed ID: 6091157 [TBL] [Abstract][Full Text] [Related]
47. The role of chloride in the sympathetic nervous system in DOCA-salt hypertension. Motoyama T; Sano H; Miki T; Suzuki H; Kawaguchi K; Furuta Y; Fukuzaki H Am J Hypertens; 1988 Jul; 1(3 Pt 1):287-90. PubMed ID: 3390322 [TBL] [Abstract][Full Text] [Related]
48. Failure of verapamil and diltiazem to attenuate the pressor response to hypothalamic stimulation: a possible mechanism. Eferakeya AE; Osunkwo UA J Pharm Pharmacol; 1992 May; 44(5):433-9. PubMed ID: 1359060 [TBL] [Abstract][Full Text] [Related]
49. Enhanced release of endothelium-derived relaxing factor in mineralocorticoid hypertension. Bockman CS; Jeffries WB; Pettinger WA; Abel PW Hypertension; 1992 Sep; 20(3):304-13. PubMed ID: 1516949 [TBL] [Abstract][Full Text] [Related]
50. Hypotensive action of taurine in DOCA-salt rats--involvement of sympathoadrenal inhibition and endogenous opiate. Sato Y; Ogata E; Fujita T Jpn Circ J; 1991 May; 55(5):500-8. PubMed ID: 2062001 [TBL] [Abstract][Full Text] [Related]
51. Differential effects of phentolamine on the responsiveness of aortic and femoral smooth muscle from normotensive and DOCA/NaCl hypertensive rats. Soltis EE; Soltis TD; Katovich MJ; Field FP Artery; 1986; 13(6):325-39. PubMed ID: 3778217 [TBL] [Abstract][Full Text] [Related]
52. A specific increase in cardiovascular reactivity related to sodium retention in DOCA-salt-treated rats. Dusting GJ; Harris GS; Rand MJ Clin Sci Mol Med; 1973 Nov; 45(5):571-81. PubMed ID: 4202410 [No Abstract] [Full Text] [Related]
53. Plasma catecholamines, noradrenaline metabolism and vascular response in desoxycorticosterone acetate hypertension of rats. Rascher W; Schömig A; Dietz R; Weber J; Gross F Eur J Pharmacol; 1981 Nov; 75(4):255-63. PubMed ID: 7318911 [TBL] [Abstract][Full Text] [Related]